Resultados de la búsqueda 131-140 of 12674 for Two-phase

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase. Defining the Immunologic Profile of Sentinel Lymph Nodes and ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for ...

3. Oncología (médica) - Ensayos clínicos

   ... phase. Defining the Immunologic Profile of Sentinel Lymph Nodes and ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of ...

7. Oncología (médica) - Ensayos clínicos

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

8. Oncología (médica) - Ensayos clínicos

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

9. Oncología (médica) - Ensayos clínicos

   Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Phase 2 part to further assess the effectiveness and safety of JCAR017 monotherapy treatment at the recommended dose. A separate Phase 1 cohort will assess ...